| Identification | |
| Name: | Lercanidipine |
| Synonyms: | (+-)-2-((3,3-Diphenylpropyl)methylamino)-1,1-dimethylethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate;3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl methyl ester;UNII-V7XTJ4R0BH;Masnidipine;AC1L244Q;3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-methyl ester; |
| CAS: | 100427-26-7 |
| Molecular Formula: | C15H19N3O5S |
| Molecular Weight: | 611.73 |
| InChI: | InChI=1/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.177 g/cm3 |
| Refractive index: | 1.579 |
| Appearance: | White to light yellow solid |
| Specification: |
Lercanidipine (100427-26-7) is a calcium channel blocker of the dihydropyridine class with appearance of white crystal. Lercanidipine (100427-26-7) is also known as Lercanidipine [INN:BAN] ; UNII-V7XTJ4R0BH ; (+-)-2-((3,3-Diphenylpropyl)methylamino)-1,1-dimethylethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate ; 3,5-Pyridinedicarboxylic acid, 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl methyl ester , Zanidip of commercial names. It is a kind of medicines in the treatment of hypertension. |
| Safety Data | |
 |
|
